Related Experiment Video
Updated: Jan 21, 2026

Personalized Peptide Arrays for Detection of HLA Alloantibodies in Organ Transplantation
Published on: September 6, 2017
Organ donor intervention trials and the ethical challenge of bystander organ recipients
1Biomedical Ethics Unit, Department of Social Studies of Medicine, McGill University, Montreal, QC, Canada.
Abstract:
Donor intervention trials test treatments aimed at preserving organs in transplantation. Many such trials apply treatments to deceased organ donors before transplantation. Drawing on a recent National Academy of Medicine report, this review describes how such studies implicate the welfare of at least four different types of individuals who would not be considered human subjects under current regulations. I close by describing why protections of some sort ought to be extended to each of these four types of research bystanders.
Insights
Donor intervention trials, which test organ preservation treatments on deceased donors, impact individuals beyond current human subject regulations. This review argues for extending protections to these research bystanders.
Area of Science:
- Medical Ethics
- Transplantation Research
- Regulatory Science
Background:
- Donor intervention trials investigate treatments to preserve organs for transplantation.
- These trials often involve interventions on deceased organ donors before organ recovery.
- Current human subject regulations may not adequately cover all individuals affected by these studies.
Purpose of the Study:
- To review the ethical implications of donor intervention trials.
- To identify individuals implicated by these trials who are not currently considered human subjects.
- To advocate for extended protections for research bystanders in transplantation.
Main Methods:
- Literature review, drawing on a National Academy of Medicine report.
- Analysis of current regulations regarding human subjects in research.
- Identification and categorization of affected research bystanders.
Main Results:
- Donor intervention trials affect at least four distinct types of individuals not currently protected under human subject regulations.
- These individuals include, but are not limited to, the donor's family and future organ recipients.
- Existing ethical frameworks may be insufficient to address the welfare of these bystanders.
Conclusions:
- Protections should be extended to individuals impacted by donor intervention trials who fall outside current human subject definitions.
- Ethical oversight in transplantation research needs to evolve to encompass a broader definition of research participants.
- Further discussion and policy development are required to ensure the welfare of all research bystanders.
Related Concept Videos
Bystander Effect
Levels of Organization
Molecules Are Composed of Atoms, and Biomolecules Are Assembled from Molecules:
The most basic levels include atoms, molecules, and biomolecules. Atoms, the smallest unit of ordinary matter, are composed of a nucleus and electrons. Molecules...
Accessory Organs
Organic Compounds
Transgenic Organisms
Organization of Genes

